(S (NP-SBJ (NP (NNS Lymphocytes)) (PP (IN from) (NP (NP (DT the) (NN site)) (PP (IN of) (NP (NN disease)))))) (VP (VBP suggest) (SBAR (-NONE- 0) (S (NP-SBJ (NN adenovirus)) (VP (VBZ is) (NP-PRD (NP (CD one) (NN cause)) (PP (IN of) (NP (ADJP-COOD (ADJP (JJ persistent)) (CC or) (ADJP (JJ recurrent))) (JJ inflammatory) (NN arthritis)))))))) (. .))
(S (NP-SBJ-64 (NP (DT The) (NN assessment)) (PP (IN of) (NP (NP (JJ synovial) (NN lymphocyte) (NN reactivity)) (PP (TO to) (NP (NN adenovirus) (NN antigen) (NN stimulation)))))) (VP (VBD was) (VP (VBN undertaken) (NP (-NONE- *-64)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP-COOD (ADJP (JJ persistent)) (CC or) (ADJP (JJ recurrent))) (JJ inflammatory) (NN arthritis))))))) (. .))
(S (NP-SBJ-65 (DT The) (JJ 3H-thymidine) (NN uptake) (NN procedure)) (VP (VBD was) (VP (VBN employed) (NP (-NONE- *-65)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG incorporating) (NP (JJ multiple) (JJ microbiological) (NNS antigens)))))) (. .))
(S (S (NP-SBJ-66 (CD Five) (NNS patients)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ (-NONE- *-66)) (PP-PRD (IN with) (NP (NP (VBN repeated) (JJ maximal) (NNS responses)) (PP (TO to) (NP (NN adenovirus) (NN antigen))))))))) (: ;) (S (PP (IN in) (NP (NP (CD one)) (PP (IN of) (NP (DT these))))) (NP-SBJ (NN adenovirus) (NN nucleotide) (NNS sequences)) (VP (VBD were) (ADJP-PRD (JJ present) (PP (IN in) (NP (DT a) (JJ synovial) (NN biopsy) (NN specimen)))))) (. .))
(S (NP-SBJ (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP-SBJ (NN adenovirus)) (VP (MD may) (VP (VB be) (NP-PRD (NP (CD one) (NN cause)) (PP (IN of) (NP (ADJP-COOD (ADJP (JJ persistent)) (CC or) (ADJP (JJ recurrent))) (JJ inflammatory) (NN arthritis)))))))))) (. .))
